‘Resist the urge always to use email’: WFH – with Square Mile’s Richard Romer-Lee
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
Author: Portfolio Adviser
-
-
Alternative thinking: How will real estate adapt to the ‘New Normal’?
In our latest spotlight on less traditional assets, Pietro Nicholls argues the future of real estate in a post-pandemic world will look very different.
-
Mike Coop: Fundamentals are your anchor in volatile markets
The outlook for markets may be blurry in the short term but, in some respects, it becomes less so over the long run
-
Christopher Bishun: How has Vanguard Lifestrategy performed compared to active alternatives?
Brooks Macdonald’s investment solutions director examines returns from the start of the coronavirus outbreak
-
‘This is a different sort of uncertainty’: WFH – with Lazard AM’s Barnaby Wilson
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Weekly outlook: Central banks mull QE firepower; UK inflation figures
The key events for UK wealth managers for the week starting 15 June
-
Stuart Freeman: Three issues that need to be on your GDPR radar
Brexit, data retention and compliance will be key GDPR considerations for financial businesses over the next 12 months
-
Richard Staveley: Stricken UK small caps can have big recovery potential
UK small companies offer a window of opportunity for investors willing to write off 2020 performance in favour of medium-term returns
-
Ben Goss on risk: Three steps to manage ESG portfolio risks
Environmental and social risks are growing, which makes managing them and investor preferences a pressing priority
-
Victoria Price: How the Covid-19 Future Fund can help start-ups
The Future Fund was recently launched to help start-ups affected by the pandemic. Who can apply and how?
-
Weekly outlook: UK braces for ‘fairly horrific’ monthly GDP and Federal Reserve meets
The key events for UK wealth managers for the week starting 8 June
-
Malcolm Schembri: Snatching at coronavirus hope could hurt investors
Potential Covid-19 breakthroughs should fuel investment in healthcare companies but shrewd stock selection will be vital